ReP USP - Resultado da busca

Artigo de periodico
Effects of probiotics in rats with experimental metabolic syndrome and periodontitis: an investigation of the intestine-adipose tissue axis (2023)
Moreira, André L. G.; Silva, Pedro H. F. ; Salvador, Sérgio L.; Ishikawa, Karin H. ; Ferreira, Graziele C. ; Santos, José E. Tanus ; Mayer, Marcia Pinto Alves ; Souza, Sérgio L. S. de ; Furlaneto, Flávia A. C. ; Messora, Michel R.
Fonte: Journal of Periodontology. Unidades: FMRP, ICB, FORP
Assuntos: MICROBIOLOGA, RATOS, DOENÇAS METABÓLICAS, PERIODONTITE, PROBIÓTICOS, TECIDO ADIPOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, André L. G. et al. Effects of probiotics in rats with experimental metabolic syndrome and periodontitis: an investigation of the intestine-adipose tissue axis. Journal of Periodontology, 2023Tradução . . Disponível em: https://doi.org/10.1002/JPER.22-0721. Acesso em: 04 jul. 2024.
APA
Moreira, A. L. G., Silva, P. H. F., Salvador, S. L., Ishikawa, K. H., Ferreira, G. C., Santos, J. E. T., et al. (2023). Effects of probiotics in rats with experimental metabolic syndrome and periodontitis: an investigation of the intestine-adipose tissue axis. Journal of Periodontology. doi:10.1002/JPER.22-0721
NLM
Moreira ALG, Silva PHF, Salvador SL, Ishikawa KH, Ferreira GC, Santos JET, Mayer MPA, Souza SLS de, Furlaneto FAC, Messora MR. Effects of probiotics in rats with experimental metabolic syndrome and periodontitis: an investigation of the intestine-adipose tissue axis [Internet]. Journal of Periodontology. 2023 ;[citado 2024 jul. 04 ] Available from: https://doi.org/10.1002/JPER.22-0721
Vancouver
Moreira ALG, Silva PHF, Salvador SL, Ishikawa KH, Ferreira GC, Santos JET, Mayer MPA, Souza SLS de, Furlaneto FAC, Messora MR. Effects of probiotics in rats with experimental metabolic syndrome and periodontitis: an investigation of the intestine-adipose tissue axis [Internet]. Journal of Periodontology. 2023 ;[citado 2024 jul. 04 ] Available from: https://doi.org/10.1002/JPER.22-0721
Artigo de periodico
Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function (2023)
Rocha, Eduardo Vieira da; Falchetti, Francisco; Pernomian, Laena; Mello, Marcela Maria Blascke de ; Parente, Juliana Montenegro ; Nogueira, Renato Corrêa; Gomes, Beatriz Quaresemin; Bertozi, Giuliana; Sanches-Lopes, Jessica M.; Tanus-Santos, José Eduardo ; Castro, Michele Mazzaron de
Fonte: Naunyn-Schmiedeberg's Archives of Pharmacology. Unidades: FMRP, FFCLRP
Assuntos: PRESSÃO SANGUÍNEA, CARDIOMEGALIA, VASOS CORONÁRIOS, HIPERTENSÃO, FARMACOTERAPIA, NEFROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Eduardo Vieira da et al. Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 396, n. 5, p. 939-949, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00210-022-02349-6. Acesso em: 04 jul. 2024.
APA
Rocha, E. V. da, Falchetti, F., Pernomian, L., Mello, M. M. B. de, Parente, J. M., Nogueira, R. C., et al. (2023). Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function. Naunyn-Schmiedeberg's Archives of Pharmacology, 396( 5), 939-949. doi:10.1007/s00210-022-02349-6
NLM
Rocha EV da, Falchetti F, Pernomian L, Mello MMB de, Parente JM, Nogueira RC, Gomes BQ, Bertozi G, Sanches-Lopes JM, Tanus-Santos JE, Castro MM de. Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2023 ; 396( 5): 939-949.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1007/s00210-022-02349-6
Vancouver
Rocha EV da, Falchetti F, Pernomian L, Mello MMB de, Parente JM, Nogueira RC, Gomes BQ, Bertozi G, Sanches-Lopes JM, Tanus-Santos JE, Castro MM de. Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2023 ; 396( 5): 939-949.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1007/s00210-022-02349-6
Artigo de periodico
The rs2682826 polymorphism of the NOS1 gene is associated with the degree of disability of erectile dysfunction (2023)
Ferezin, Letícia Perticarrara; Cotta Filho, Cezar Kayzuka ; Pereira, Vitória Carolina Rondon; Andrade, Murilo Ferreira de; Molina, Carlos Augusto Fernandes ; Tucci Júnior, Silvio ; Tanus-Santos, José Eduardo ; Lacchini, Riccardo
Fonte: Life. Unidades: FMRP, EERP
Assuntos: DISFUNÇÃO ERÉTIL, POLIMORFISMO, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FEREZIN, Letícia Perticarrara et al. The rs2682826 polymorphism of the NOS1 gene is associated with the degree of disability of erectile dysfunction. Life, v. 13, n. 5, p. 1-13, 2023Tradução . . Disponível em: https://doi.org/10.3390/life13051082. Acesso em: 04 jul. 2024.
APA
Ferezin, L. P., Cotta Filho, C. K., Pereira, V. C. R., Andrade, M. F. de, Molina, C. A. F., Tucci Júnior, S., et al. (2023). The rs2682826 polymorphism of the NOS1 gene is associated with the degree of disability of erectile dysfunction. Life, 13( 5), 1-13. doi:10.3390/life13051082
NLM
Ferezin LP, Cotta Filho CK, Pereira VCR, Andrade MF de, Molina CAF, Tucci Júnior S, Tanus-Santos JE, Lacchini R. The rs2682826 polymorphism of the NOS1 gene is associated with the degree of disability of erectile dysfunction [Internet]. Life. 2023 ; 13( 5): 1-13.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3390/life13051082
Vancouver
Ferezin LP, Cotta Filho CK, Pereira VCR, Andrade MF de, Molina CAF, Tucci Júnior S, Tanus-Santos JE, Lacchini R. The rs2682826 polymorphism of the NOS1 gene is associated with the degree of disability of erectile dysfunction [Internet]. Life. 2023 ; 13( 5): 1-13.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3390/life13051082
Artigo de periodico
On the origin of nitrosylated hemoglobin in COVID-19: endothelial NO capture or redox conversion of nitrite? experimental results and a cautionary note on challenges in translational research (2022)
Nogueira, Renato Corrêa; Minnion, Magdalena; Clark, Anna D.; Dyson, Alex; Tanus-Santos, José Eduardo ; Feelisch, Martin
Fonte: Redox Biology. Unidade: FMRP
Assuntos: COVID-19, ESPECTROSCOPIA DE RESSONÂNCIA MAGNÉTICA NUCLEAR, ENDOTÉLIO, HEMOGLOBINAS, ÓXIDO NÍTRICO, PESQUISA BIOMÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOGUEIRA, Renato Corrêa et al. On the origin of nitrosylated hemoglobin in COVID-19: endothelial NO capture or redox conversion of nitrite? experimental results and a cautionary note on challenges in translational research. Redox Biology, v. 54, p. 1-6, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.redox.2022.102362. Acesso em: 04 jul. 2024.
APA
Nogueira, R. C., Minnion, M., Clark, A. D., Dyson, A., Tanus-Santos, J. E., & Feelisch, M. (2022). On the origin of nitrosylated hemoglobin in COVID-19: endothelial NO capture or redox conversion of nitrite? experimental results and a cautionary note on challenges in translational research. Redox Biology, 54, 1-6. doi:10.1016/j.redox.2022.102362
NLM
Nogueira RC, Minnion M, Clark AD, Dyson A, Tanus-Santos JE, Feelisch M. On the origin of nitrosylated hemoglobin in COVID-19: endothelial NO capture or redox conversion of nitrite? experimental results and a cautionary note on challenges in translational research [Internet]. Redox Biology. 2022 ; 54 1-6.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.redox.2022.102362
Vancouver
Nogueira RC, Minnion M, Clark AD, Dyson A, Tanus-Santos JE, Feelisch M. On the origin of nitrosylated hemoglobin in COVID-19: endothelial NO capture or redox conversion of nitrite? experimental results and a cautionary note on challenges in translational research [Internet]. Redox Biology. 2022 ; 54 1-6.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.redox.2022.102362
Artigo de periodico
The association of biochemical and genetic biomarkers in VEGF pathway with depression (2022)
Nunes, Fernanda Daniela Dornelas; Ferezin, Letícia Perticarrara; Pereira, Sherliane Carla ; Figaro-Drumond, Fernanda Viana; Pinheiro, Lucas Cezar ; Menezes, Itiana Castro; Baes, Cristiane Von Werne ; Coeli-Lacchini, Fernanda Borchers ; Tanus-Santos, José Eduardo ; Juruena, Mario Francisco; Lacchini, Riccardo
Fonte: Pharmaceutics. Unidades: EERP, FMRP
Assuntos: DEPRESSÃO, COMPORTAMENTO DE RISCO, SUICIDAS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Fernanda Daniela Dornelas et al. The association of biochemical and genetic biomarkers in VEGF pathway with depression. Pharmaceutics, v. 14, n. 12, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14122757. Acesso em: 04 jul. 2024.
APA
Nunes, F. D. D., Ferezin, L. P., Pereira, S. C., Figaro-Drumond, F. V., Pinheiro, L. C., Menezes, I. C., et al. (2022). The association of biochemical and genetic biomarkers in VEGF pathway with depression. Pharmaceutics, 14( 12), 1-15. doi:10.3390/pharmaceutics14122757
NLM
Nunes FDD, Ferezin LP, Pereira SC, Figaro-Drumond FV, Pinheiro LC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Tanus-Santos JE, Juruena MF, Lacchini R. The association of biochemical and genetic biomarkers in VEGF pathway with depression [Internet]. Pharmaceutics. 2022 ; 14( 12): 1-15.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3390/pharmaceutics14122757
Vancouver
Nunes FDD, Ferezin LP, Pereira SC, Figaro-Drumond FV, Pinheiro LC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Tanus-Santos JE, Juruena MF, Lacchini R. The association of biochemical and genetic biomarkers in VEGF pathway with depression [Internet]. Pharmaceutics. 2022 ; 14( 12): 1-15.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3390/pharmaceutics14122757
Artigo de periodico
Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress (2022)
Silva-Neto, Pedro V. da; Valle, Valéria Beatriz do; Fuzo, Carlos Alessandro; Fernandes, Talita Morais; Toro, Diana Mota; Silva, Thais Fernanda de Campos Fraga da; Basile, Patrícia Adriana; Carvalho, Jonatan Constança Silva de; Pimentel, Vinícius Eduardo; Pérez, Malena Martínez; Oliveira, Camilla Narjara Simão; Rodrigues, Lilian Cataldi ; Bastos, Victor Alexandre Félix; Tella, Sandra de Oliveira Conde; Martins, Ronaldo Bragança; Degiovani, Augusto Marcussi; Ostini, Fátima M.; Feitosa, Marley Ribeiro; Parra, Rogério Serafim; Vilar, Fernando Crivelenti; Gaspar, Gilberto Gambero; Rocha, José Joaquim Ribeiro da ; Féres, Omar; Arruda, Eurico; Maruyama, Sandra R.; Russo, Elisa Maria de Sousa ; Viana, Angelina Lettiere ; Santos, Isabel Kinney Ferreira de Miranda; Bonato, Vânia Luiza Deperon; Cardoso, Cristina Ribeiro de Barros; Tanus-Santos, José Eduardo ; Donadi, Eduardo Antônio; Faccioli, Lucia Helena ; Dias-Baruffi, Marcelo; Fernandes, Ana Paula Morais; Gerlach, Raquel Fernanda; Sorgi, Carlos Arterio
Fonte: Biomolecules. Unidades: FORP, FCFRP, FMRP, EERP, FFCLRP
Assuntos: METALOPROTEINASES, PEROXIDASE, LIPÍDEOS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA-NETO, Pedro V. da et al. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress. Biomolecules, v. 12, n. 5, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.3390/biom12050604. Acesso em: 04 jul. 2024.
APA
Silva-Neto, P. V. da, Valle, V. B. do, Fuzo, C. A., Fernandes, T. M., Toro, D. M., Silva, T. F. de C. F. da, et al. (2022). Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress. Biomolecules, 12( 5), 1-20. doi:10.3390/biom12050604
NLM
Silva-Neto PV da, Valle VB do, Fuzo CA, Fernandes TM, Toro DM, Silva TF de CF da, Basile PA, Carvalho JCS de, Pimentel VE, Pérez MM, Oliveira CNS, Rodrigues LC, Bastos VAF, Tella S de OC, Martins RB, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJR da, Féres O, Arruda E, Maruyama SR, Russo EM de S, Viana AL, Santos IKF de M, Bonato VLD, Cardoso CR de B, Tanus-Santos JE, Donadi EA, Faccioli LH, Dias-Baruffi M, Fernandes APM, Gerlach RF, Sorgi CA. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress [Internet]. Biomolecules. 2022 ; 12( 5): 1-20.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3390/biom12050604
Vancouver
Silva-Neto PV da, Valle VB do, Fuzo CA, Fernandes TM, Toro DM, Silva TF de CF da, Basile PA, Carvalho JCS de, Pimentel VE, Pérez MM, Oliveira CNS, Rodrigues LC, Bastos VAF, Tella S de OC, Martins RB, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJR da, Féres O, Arruda E, Maruyama SR, Russo EM de S, Viana AL, Santos IKF de M, Bonato VLD, Cardoso CR de B, Tanus-Santos JE, Donadi EA, Faccioli LH, Dias-Baruffi M, Fernandes APM, Gerlach RF, Sorgi CA. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress [Internet]. Biomolecules. 2022 ; 12( 5): 1-20.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3390/biom12050604
Artigo de periodico
TRPA1 polymorphisms modify the hypotensive responses to propofol with no change in nitrite or nitrate levels (2022)
Melo, Isabela Borges de; Oliveira-Paula, Gustavo Henrique; Ferezin, Letícia Perticarrara; Ferreira, Graziele Cristina ; Pinheiro, Lucas Cezar ; Tanus-Santos, José Eduardo ; Garcia, Luis Vicente ; Lacchini, Riccardo ; Garcia, Waynice Neiva de Paula
Fonte: Current Issues in Molecular Biology. Unidades: FMRP, EERP
Assuntos: MEDICAMENTO, PRESSÃO SANGUÍNEA, POLIMORFISMO, ÓXIDO NÍTRICO, ANESTÉSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELO, Isabela Borges de et al. TRPA1 polymorphisms modify the hypotensive responses to propofol with no change in nitrite or nitrate levels. Current Issues in Molecular Biology, v. 44, n. 12, p. 6333-6345, 2022Tradução . . Disponível em: https://doi.org/10.3390/cimb44120432. Acesso em: 04 jul. 2024.
APA
Melo, I. B. de, Oliveira-Paula, G. H., Ferezin, L. P., Ferreira, G. C., Pinheiro, L. C., Tanus-Santos, J. E., et al. (2022). TRPA1 polymorphisms modify the hypotensive responses to propofol with no change in nitrite or nitrate levels. Current Issues in Molecular Biology, 44( 12), 6333-6345. doi:10.3390/cimb44120432
NLM
Melo IB de, Oliveira-Paula GH, Ferezin LP, Ferreira GC, Pinheiro LC, Tanus-Santos JE, Garcia LV, Lacchini R, Garcia WN de P. TRPA1 polymorphisms modify the hypotensive responses to propofol with no change in nitrite or nitrate levels [Internet]. Current Issues in Molecular Biology. 2022 ; 44( 12): 6333-6345.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3390/cimb44120432
Vancouver
Melo IB de, Oliveira-Paula GH, Ferezin LP, Ferreira GC, Pinheiro LC, Tanus-Santos JE, Garcia LV, Lacchini R, Garcia WN de P. TRPA1 polymorphisms modify the hypotensive responses to propofol with no change in nitrite or nitrate levels [Internet]. Current Issues in Molecular Biology. 2022 ; 44( 12): 6333-6345.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3390/cimb44120432
Artigo de periodico
NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia (2021)
Pereira, Daniela A.; Sandrim, Valeria C.; Palei, Ana C.; Amaral, Lorena M.; Belo, Vanessa A.; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho; Tanus-Santos, José Eduardo ; Luizon, Marcelo R.
Fonte: Pharmacogenomics. Unidades: EERP, FMRP
Assuntos: FÁRMACOS (SISTEMA CARDIOVASCULAR), CITOCINAS, ÓXIDO NÍTRICO, POLIMORFISMO, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Daniela A. et al. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, v. 22, n. 8, p. 451-464, 2021Tradução . . Disponível em: https://doi.org/10.2217/pgs-2021-0006. Acesso em: 04 jul. 2024.
APA
Pereira, D. A., Sandrim, V. C., Palei, A. C., Amaral, L. M., Belo, V. A., Lacchini, R., et al. (2021). NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, 22( 8), 451-464. doi:10.2217/pgs-2021-0006
NLM
Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2024 jul. 04 ] Available from: https://doi.org/10.2217/pgs-2021-0006
Vancouver
Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2024 jul. 04 ] Available from: https://doi.org/10.2217/pgs-2021-0006
Artigo de periodico
Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability (2021)
Oliveira-Paula, Gustavo Henrique; Coeli-Lacchini, Fernanda Borchers; Ferezin, Letícia Perticarrara; Ferreira, Graziele Cristina ; Pinheiro, Lucas Cezar ; Garcia, Waynice Neiva de Paula ; Garcia, Luis Vicente ; Tanus-Santos, José Eduardo ; Lacchini, Riccardo
Fonte: European Journal of Clinical Pharmacology. Unidades: FMRP, EERP, FCFRP
Assuntos: MEDICAMENTO, POLIMORFISMO, ÓXIDO NÍTRICO, ANESTESIA, PRESSÃO SANGUÍNEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-PAULA, Gustavo Henrique et al. Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability. European Journal of Clinical Pharmacology, v. 77, n. 6, p. 869-877, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00228-020-03059-9. Acesso em: 04 jul. 2024.
APA
Oliveira-Paula, G. H., Coeli-Lacchini, F. B., Ferezin, L. P., Ferreira, G. C., Pinheiro, L. C., Garcia, W. N. de P., et al. (2021). Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability. European Journal of Clinical Pharmacology, 77( 6), 869-877. doi:10.1007/s00228-020-03059-9
NLM
Oliveira-Paula GH, Coeli-Lacchini FB, Ferezin LP, Ferreira GC, Pinheiro LC, Garcia WN de P, Garcia LV, Tanus-Santos JE, Lacchini R. Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability [Internet]. European Journal of Clinical Pharmacology. 2021 ; 77( 6): 869-877.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1007/s00228-020-03059-9
Vancouver
Oliveira-Paula GH, Coeli-Lacchini FB, Ferezin LP, Ferreira GC, Pinheiro LC, Garcia WN de P, Garcia LV, Tanus-Santos JE, Lacchini R. Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability [Internet]. European Journal of Clinical Pharmacology. 2021 ; 77( 6): 869-877.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1007/s00228-020-03059-9
Artigo de periodico
Association between endothelial nitric oxide synthase and the renin-angiotensin-aldosterone system polymorphisms, blood pressure and training status in normotensive/pre-hypertension and hypertensive older adults: a pilot study (2021)
Silva, Roberta Fernanda da; Lacchini, Riccardo ; Pinheiro, Lucas Cezar ; Ferezin, Letícia Perticarrara; Tanus-Santos, José Eduardo ; Luizon, Marcelo Rizzatti; Dionísio, Thiago José; Santos, Carlos Ferreira dos ; Reia, Thaís Amanda; Jacomini, André Mourão; Moreno, Ana Maria Guilmo; Zago, Anderson Saranz
Fonte: Clinical and Experimental Hypertension. Unidades: EERP, FMRP, FOB
Assuntos: ENVELHECIMENTO, EXERCÍCIO FÍSICO, HEREDITARIEDADE, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Roberta Fernanda da et al. Association between endothelial nitric oxide synthase and the renin-angiotensin-aldosterone system polymorphisms, blood pressure and training status in normotensive/pre-hypertension and hypertensive older adults: a pilot study. Clinical and Experimental Hypertension, v. 43, n. 7, p. 661-670, 2021Tradução . . Disponível em: https://doi.org/10.1080/10641963.2021.1937202. Acesso em: 04 jul. 2024.
APA
Silva, R. F. da, Lacchini, R., Pinheiro, L. C., Ferezin, L. P., Tanus-Santos, J. E., Luizon, M. R., et al. (2021). Association between endothelial nitric oxide synthase and the renin-angiotensin-aldosterone system polymorphisms, blood pressure and training status in normotensive/pre-hypertension and hypertensive older adults: a pilot study. Clinical and Experimental Hypertension, 43( 7), 661-670. doi:10.1080/10641963.2021.1937202
NLM
Silva RF da, Lacchini R, Pinheiro LC, Ferezin LP, Tanus-Santos JE, Luizon MR, Dionísio TJ, Santos CF dos, Reia TA, Jacomini AM, Moreno AMG, Zago AS. Association between endothelial nitric oxide synthase and the renin-angiotensin-aldosterone system polymorphisms, blood pressure and training status in normotensive/pre-hypertension and hypertensive older adults: a pilot study [Internet]. Clinical and Experimental Hypertension. 2021 ; 43( 7): 661-670.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1080/10641963.2021.1937202
Vancouver
Silva RF da, Lacchini R, Pinheiro LC, Ferezin LP, Tanus-Santos JE, Luizon MR, Dionísio TJ, Santos CF dos, Reia TA, Jacomini AM, Moreno AMG, Zago AS. Association between endothelial nitric oxide synthase and the renin-angiotensin-aldosterone system polymorphisms, blood pressure and training status in normotensive/pre-hypertension and hypertensive older adults: a pilot study [Internet]. Clinical and Experimental Hypertension. 2021 ; 43( 7): 661-670.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1080/10641963.2021.1937202
Artigo de periodico
Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension (2021)
Guimarães, Danielle Aparecida; Batista, Rose Inês Matos ; Tanus-Santos, José Eduardo
Fonte: Basic & Clinical Pharmacology & Toxicology. Unidade: FMRP
Assuntos: FÁRMACOS (SISTEMA CARDIOVASCULAR), ARTÉRIAS, HIPERTENSÃO, HIPERTROFIA VENTRICULAR ESQUERDA, NITRATOS, ÓXIDO NÍTRICO, ESTRESSE OXIDATIVO, SISTEMA RENINA-ANGIOTENSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Danielle Aparecida e BATISTA, Rose Inês Matos e TANUS-SANTOS, José Eduardo. Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension. Basic & Clinical Pharmacology & Toxicology, v. 128, n. 1, p. 9-17, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13474. Acesso em: 04 jul. 2024.
APA
Guimarães, D. A., Batista, R. I. M., & Tanus-Santos, J. E. (2021). Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension. Basic & Clinical Pharmacology & Toxicology, 128( 1), 9-17. doi:10.1111/bcpt.13474
NLM
Guimarães DA, Batista RIM, Tanus-Santos JE. Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 128( 1): 9-17.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1111/bcpt.13474
Vancouver
Guimarães DA, Batista RIM, Tanus-Santos JE. Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 128( 1): 9-17.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1111/bcpt.13474
Artigo de periodico
Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism (2021)
Neto-Neves, Evandro Manoel; Sousa-Santos, Ozelia; Ferraz, Karina C.; Portella, Rafael L.; Sertorio, Jonas T.; Tanus-Santos, José Eduardo
Fonte: Nitric Oxide. Unidade: FMRP
Assuntos: DOENÇA AGUDA, TROMBOFLEBITE, ANTIOXIDANTES, VENTRÍCULO CARDÍACO, HIPERTENSÃO PULMONAR, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NETO-NEVES, Evandro Manoel et al. Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism. Nitric Oxide, v. 115, p. 23-29, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2021.06.004. Acesso em: 04 jul. 2024.
APA
Neto-Neves, E. M., Sousa-Santos, O., Ferraz, K. C., Portella, R. L., Sertorio, J. T., & Tanus-Santos, J. E. (2021). Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism. Nitric Oxide, 115, 23-29. doi:10.1016/j.niox.2021.06.004
NLM
Neto-Neves EM, Sousa-Santos O, Ferraz KC, Portella RL, Sertorio JT, Tanus-Santos JE. Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism [Internet]. Nitric Oxide. 2021 ; 115 23-29.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.niox.2021.06.004
Vancouver
Neto-Neves EM, Sousa-Santos O, Ferraz KC, Portella RL, Sertorio JT, Tanus-Santos JE. Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism [Internet]. Nitric Oxide. 2021 ; 115 23-29.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.niox.2021.06.004
Artigo de periodico
Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol (2021)
Paula, Gustavo Henrique Oliveira de; Pereira, Daniela A.; Pinheiro, Lucas Cezar ; Ferreira, Graziele Cristina ; Garcia, Waynice Neiva de Paula ; Garcia, Luis Vicente ; Lacchini, Riccardo ; Luizon, Marcelo R.; Tanus-Santos, José Eduardo
Fonte: Basic & Clinical Pharmacology & Toxicology. Unidades: FMRP, EERP
Assuntos: ANESTÉSICOS INTRAVENOSOS, ESTUDOS TRANSVERSAIS, GENÓTIPOS, HAPLOTIPOS, HIPOTENSÃO, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULA, Gustavo Henrique Oliveira de et al. Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol. Basic & Clinical Pharmacology & Toxicology, v. 130, n. 2, p. 277-287, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13691. Acesso em: 04 jul. 2024.
APA
Paula, G. H. O. de, Pereira, D. A., Pinheiro, L. C., Ferreira, G. C., Garcia, W. N. de P., Garcia, L. V., et al. (2021). Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol. Basic & Clinical Pharmacology & Toxicology, 130( 2), 277-287. doi:10.1111/bcpt.13691
NLM
Paula GHO de, Pereira DA, Pinheiro LC, Ferreira GC, Garcia WN de P, Garcia LV, Lacchini R, Luizon MR, Tanus-Santos JE. Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 130( 2): 277-287.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1111/bcpt.13691
Vancouver
Paula GHO de, Pereira DA, Pinheiro LC, Ferreira GC, Garcia WN de P, Garcia LV, Lacchini R, Luizon MR, Tanus-Santos JE. Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 130( 2): 277-287.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1111/bcpt.13691
Artigo de periodico
A new mixed model of periodontitis‐induced preeclampsia: a pilot study (2021)
Mata, Karina Magalhães Alves da; Nobre, Átila Vinicius Vitor; Silva, Pedro Henrique Felix ; Oliezer, Renê Seabra ; Fernandes, Cleverson Rodrigues; Amaral, Jefferson Henrich; Ramos, Junia; Mastrange, Marina Del Arco; Messora, Michel Reis; Santos, José Eduardo Tanus dos ; Gerlach, Raquel Fernanda; Salvador, Sérgio Luiz de Souza
Fonte: Journal of Periodontal Research. Unidades: FORP, FCFRP, FMRP
Assuntos: PERIODONTITE, PORPHYROMONAS GINGIVALIS, PRÉ-ECLÂMPSIA, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATA, Karina Magalhães Alves da et al. A new mixed model of periodontitis‐induced preeclampsia: a pilot study. Journal of Periodontal Research, v. 56, n. 4, p. 726-734, 2021Tradução . . Disponível em: https://doi.org/10.1111/jre.12869. Acesso em: 04 jul. 2024.
APA
Mata, K. M. A. da, Nobre, Á. V. V., Silva, P. H. F., Oliezer, R. S., Fernandes, C. R., Amaral, J. H., et al. (2021). A new mixed model of periodontitis‐induced preeclampsia: a pilot study. Journal of Periodontal Research, 56( 4), 726-734. doi:10.1111/jre.12869
NLM
Mata KMA da, Nobre ÁVV, Silva PHF, Oliezer RS, Fernandes CR, Amaral JH, Ramos J, Mastrange MDA, Messora MR, Santos JET dos, Gerlach RF, Salvador SL de S. A new mixed model of periodontitis‐induced preeclampsia: a pilot study [Internet]. Journal of Periodontal Research. 2021 ; 56( 4): 726-734.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1111/jre.12869
Vancouver
Mata KMA da, Nobre ÁVV, Silva PHF, Oliezer RS, Fernandes CR, Amaral JH, Ramos J, Mastrange MDA, Messora MR, Santos JET dos, Gerlach RF, Salvador SL de S. A new mixed model of periodontitis‐induced preeclampsia: a pilot study [Internet]. Journal of Periodontal Research. 2021 ; 56( 4): 726-734.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1111/jre.12869
Artigo de periodico
The use of probiotics can reduce the severity of experimental periodontitis in rats with metabolic syndrome: an immunoenzymatic and microtomographic study (2021)
Silva, Giselle Aparecida da; Moreira, André Luis Gomes; Silva, Pedro Henrique Felix ; Salvador, Sérgio Luiz de Souza ; Casarin, Renato C. V.; Vicente, Raphael Martini; Ferreira, Graziele Cristina ; Tanus-Santos, José Eduardo ; Furlaneto, Flavia Aparecida Chaves ; Messora, Michel Reis
Fonte: Journal of Periodontology. Unidades: FCFRP, FMRP, FORP
Assuntos: BACTÉRIAS ANAERÓBICAS, PROBIÓTICOS, PERIODONTITE, NECROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Giselle Aparecida da et al. The use of probiotics can reduce the severity of experimental periodontitis in rats with metabolic syndrome: an immunoenzymatic and microtomographic study. Journal of Periodontology, v. 93, n. 2, p. e1-e12, 2021Tradução . . Disponível em: https://doi.org/10.1002/JPER.21-0285. Acesso em: 04 jul. 2024.
APA
Silva, G. A. da, Moreira, A. L. G., Silva, P. H. F., Salvador, S. L. de S., Casarin, R. C. V., Vicente, R. M., et al. (2021). The use of probiotics can reduce the severity of experimental periodontitis in rats with metabolic syndrome: an immunoenzymatic and microtomographic study. Journal of Periodontology, 93( 2), e1-e12. doi:10.1002/JPER.21-0285
NLM
Silva GA da, Moreira ALG, Silva PHF, Salvador SL de S, Casarin RCV, Vicente RM, Ferreira GC, Tanus-Santos JE, Furlaneto FAC, Messora MR. The use of probiotics can reduce the severity of experimental periodontitis in rats with metabolic syndrome: an immunoenzymatic and microtomographic study [Internet]. Journal of Periodontology. 2021 ; 93( 2): e1-e12.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1002/JPER.21-0285
Vancouver
Silva GA da, Moreira ALG, Silva PHF, Salvador SL de S, Casarin RCV, Vicente RM, Ferreira GC, Tanus-Santos JE, Furlaneto FAC, Messora MR. The use of probiotics can reduce the severity of experimental periodontitis in rats with metabolic syndrome: an immunoenzymatic and microtomographic study [Internet]. Journal of Periodontology. 2021 ; 93( 2): e1-e12.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1002/JPER.21-0285
Artigo de periodico
Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation (2021)
Nogueira, Renato Corrêa; Pinheiro, Lucas Cezar ; Sanches-Lopes, Jessica M.; Parente, Juliana Montenegro; Oliveira-Paula, Gustavo Henrique; Tella, Sandra de Oliveira Conde; Castro, Michele Mazzaron de; Tanus-Santos, José Eduardo
Fonte: Biochemical Pharmacology. Unidades: EERP, FMRP
Assuntos: AORTA, INIBIDORES DE ENZIMAS, REGULAÇÃO GÊNICA, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOGUEIRA, Renato Corrêa et al. Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation. Biochemical Pharmacology, v. 190, p. 1-10, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2021.114633. Acesso em: 04 jul. 2024.
APA
Nogueira, R. C., Pinheiro, L. C., Sanches-Lopes, J. M., Parente, J. M., Oliveira-Paula, G. H., Tella, S. de O. C., et al. (2021). Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation. Biochemical Pharmacology, 190, 1-10. doi:10.1016/j.bcp.2021.114633
NLM
Nogueira RC, Pinheiro LC, Sanches-Lopes JM, Parente JM, Oliveira-Paula GH, Tella S de OC, Castro MM de, Tanus-Santos JE. Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation [Internet]. Biochemical Pharmacology. 2021 ; 190 1-10.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.bcp.2021.114633
Vancouver
Nogueira RC, Pinheiro LC, Sanches-Lopes JM, Parente JM, Oliveira-Paula GH, Tella S de OC, Castro MM de, Tanus-Santos JE. Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation [Internet]. Biochemical Pharmacology. 2021 ; 190 1-10.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.bcp.2021.114633
Artigo de periodico
Circulating total cell-free DNA levels are increased in hypertensive disorders of pregnancy and associated with prohypertensive factors and adverse clinical outcomes (2021)
Amaral, Lorena M.; Sandrim, Valeria C.; Kutcher, Matthew E.; Spradley, Frank T.; Cavalli, Ricardo de Carvalho ; Tanus-Santos, José Eduardo ; Palei, Ana C.
Fonte: International Journal of Molecular Sciences. Unidade: FMRP
Assuntos: BIOMARCADORES, DNA, HIPERTENSÃO NA GRAVIDEZ, PRÉ-ECLÂMPSIA, COMPLICAÇÕES NA GRAVIDEZ, ESPECTROMETRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Lorena M. et al. Circulating total cell-free DNA levels are increased in hypertensive disorders of pregnancy and associated with prohypertensive factors and adverse clinical outcomes. International Journal of Molecular Sciences, v. 22, n. 2, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22020564. Acesso em: 04 jul. 2024.
APA
Amaral, L. M., Sandrim, V. C., Kutcher, M. E., Spradley, F. T., Cavalli, R. de C., Tanus-Santos, J. E., & Palei, A. C. (2021). Circulating total cell-free DNA levels are increased in hypertensive disorders of pregnancy and associated with prohypertensive factors and adverse clinical outcomes. International Journal of Molecular Sciences, 22( 2), 1-16. doi:10.3390/ijms22020564
NLM
Amaral LM, Sandrim VC, Kutcher ME, Spradley FT, Cavalli R de C, Tanus-Santos JE, Palei AC. Circulating total cell-free DNA levels are increased in hypertensive disorders of pregnancy and associated with prohypertensive factors and adverse clinical outcomes [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 2): 1-16.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3390/ijms22020564
Vancouver
Amaral LM, Sandrim VC, Kutcher ME, Spradley FT, Cavalli R de C, Tanus-Santos JE, Palei AC. Circulating total cell-free DNA levels are increased in hypertensive disorders of pregnancy and associated with prohypertensive factors and adverse clinical outcomes [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 2): 1-16.[citado 2024 jul. 04 ] Available from: https://doi.org/10.3390/ijms22020564
Artigo de periodico
Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II (2021)
Pinheiro, Lucas Cezar ; Oliveira-Paula, Gustavo Henrique; Ferreira, Graziele Cristina ; Paula, Tiago Dal-Cin de; Duarte, Diego Ângelo; Costa Neto, Cláudio Miguel; Tanus-Santos, José Eduardo
Fonte: Redox Report. Unidades: EERP, FMRP
Assuntos: ANGIOTENSINA II, ÓXIDO NÍTRICO, NITRITOS, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, Lucas Cezar et al. Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II. Redox Report, v. 38, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.redox.2020.101769. Acesso em: 04 jul. 2024.
APA
Pinheiro, L. C., Oliveira-Paula, G. H., Ferreira, G. C., Paula, T. D. -C. de, Duarte, D. Â., Costa Neto, C. M., & Tanus-Santos, J. E. (2021). Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II. Redox Report, 38, 1-11. doi:10.1016/j.redox.2020.101769
NLM
Pinheiro LC, Oliveira-Paula GH, Ferreira GC, Paula TD-C de, Duarte DÂ, Costa Neto CM, Tanus-Santos JE. Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II [Internet]. Redox Report. 2021 ; 38 1-11.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.redox.2020.101769
Vancouver
Pinheiro LC, Oliveira-Paula GH, Ferreira GC, Paula TD-C de, Duarte DÂ, Costa Neto CM, Tanus-Santos JE. Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II [Internet]. Redox Report. 2021 ; 38 1-11.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.redox.2020.101769
Artigo de periodico
Antioxidant tempol modulates the increases in tissue nitric oxide metabolites concentrations after oral nitrite administration (2021)
Ferreira, Graziele C.; Pinheiro, Lucas C.; Oliveira-Paula, Gustavo Henrique; Angelis, Célio D.; Portella, Rafael L.; Tanus-Santos, José Eduardo
Fonte: Chemico-Biological Interactions. Unidades: EERP, FMRP
Assuntos: NITRITOS, ÓXIDO NÍTRICO, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Graziele C. et al. Antioxidant tempol modulates the increases in tissue nitric oxide metabolites concentrations after oral nitrite administration. Chemico-Biological Interactions, v. 349, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2021.109658. Acesso em: 04 jul. 2024.
APA
Ferreira, G. C., Pinheiro, L. C., Oliveira-Paula, G. H., Angelis, C. D., Portella, R. L., & Tanus-Santos, J. E. (2021). Antioxidant tempol modulates the increases in tissue nitric oxide metabolites concentrations after oral nitrite administration. Chemico-Biological Interactions, 349. doi:10.1016/j.cbi.2021.109658
NLM
Ferreira GC, Pinheiro LC, Oliveira-Paula GH, Angelis CD, Portella RL, Tanus-Santos JE. Antioxidant tempol modulates the increases in tissue nitric oxide metabolites concentrations after oral nitrite administration [Internet]. Chemico-Biological Interactions. 2021 ; 349[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.cbi.2021.109658
Vancouver
Ferreira GC, Pinheiro LC, Oliveira-Paula GH, Angelis CD, Portella RL, Tanus-Santos JE. Antioxidant tempol modulates the increases in tissue nitric oxide metabolites concentrations after oral nitrite administration [Internet]. Chemico-Biological Interactions. 2021 ; 349[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.cbi.2021.109658
Artigo de periodico
Antiseptic mouthwash inhibits antihypertensive and vascular protective effects of L-arginine (2021)
Batista, Rose I.M.; Nogueira, Renato C.; Ferreira, Graziele C.; Oliveira-Paula, Gustavo H.; Damacena-Angelis, Célio; Pinheiro, Lucas C.; Tanus-Santos, José Eduardo
Fonte: European Journal of Pharmacology. Unidades: FMRP, EERP
Assuntos: ÓXIDO NÍTRICO, NITRITOS, NITRATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BATISTA, Rose I.M. et al. Antiseptic mouthwash inhibits antihypertensive and vascular protective effects of L-arginine. European Journal of Pharmacology, v. 907, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2021.174314. Acesso em: 04 jul. 2024.
APA
Batista, R. I. M., Nogueira, R. C., Ferreira, G. C., Oliveira-Paula, G. H., Damacena-Angelis, C., Pinheiro, L. C., & Tanus-Santos, J. E. (2021). Antiseptic mouthwash inhibits antihypertensive and vascular protective effects of L-arginine. European Journal of Pharmacology, 907. doi:10.1016/j.ejphar.2021.174314
NLM
Batista RIM, Nogueira RC, Ferreira GC, Oliveira-Paula GH, Damacena-Angelis C, Pinheiro LC, Tanus-Santos JE. Antiseptic mouthwash inhibits antihypertensive and vascular protective effects of L-arginine [Internet]. European Journal of Pharmacology. 2021 ; 907[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.ejphar.2021.174314
Vancouver
Batista RIM, Nogueira RC, Ferreira GC, Oliveira-Paula GH, Damacena-Angelis C, Pinheiro LC, Tanus-Santos JE. Antiseptic mouthwash inhibits antihypertensive and vascular protective effects of L-arginine [Internet]. European Journal of Pharmacology. 2021 ; 907[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.ejphar.2021.174314

Unidades USP

ReP

Filtros

Tipo de material

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada